REG - Genedrive PLC - Block Listing Returns

GenedriveAnnouncement

31/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230531:nRSe0413Ba&default-theme=true

RNS Number : 0413B  Genedrive PLC  31 May 2023

 

genedrive plc

("genedrive" or the "Company")

 

Block Listing Returns

 

The Company confirms the block listing six monthly return for the period to 31
May 2023.

 

 Name of applicant                                                               genedrive plc

 Name of scheme                                                                  2007 Share Option Scheme

 Period of return:                       From:                                   01 December 2022  To:         31 May 2023
 Balance of unallocated securities under scheme(s) from previous return:         139,226 shares

 Plus: The amount by which the block scheme(s) has been increased since the      Nil
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period       7,500 shares
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:      131,726 shares

 

In order to co-terminate future block listing returns the Company confirms the
following returns for the two block listings granted earlier in the month.

 

 Name of applicant                                                               genedrive plc

 Name of scheme                                                                  2017 Share Option Scheme

 Period of return:                       From:                                   19 May 2023  To:         31 May 2023
 Balance of unallocated securities under scheme(s) from previous return:         1,150,588 shares

 Plus: The amount by which the block scheme(s) has been increased since the      Nil
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period       Nil
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:      1,150,588 shares

 

 Name of applicant                                                               genedrive plc

 Name of scheme                                                                  Unapproved Share Option Scheme

 Period of return:                       From:                                   19 May 2023  To:           31 May 2023
 Balance of unallocated securities under scheme(s) from previous return:         2,668,144 shares

 Plus: The amount by which the block scheme(s) has been increased since the      Nil
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period       Nil
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:      2,668,144  shares

 Name of contact:                                                                Russ Shaw CFO
 Telephone number of contact:                                                    +44 (0)161 989 0245

 

For enquires:

 

 genedrive plc                                                                               +44 (0)161 989 0245
 David Budd: CEO / Russ Shaw: CFO

 Peel Hunt LLP (Nominated Adviser and Joint Broker)                                          +44 (0)20 7418 8900
 James Steel / Oliver Duckworth

 finnCap (Joint Broker)                                                                      +44 (0)20 7220 500
 Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

 Walbrook PR Ltd (Media Relations & Investor Relations)       +44 (0)20 7933 8780 or genedrive@walbrookpr.com
                                                              (mailto:genedrive@walbrookpr.com)
 Paul McManus / Anna Dunphy                                                                  +44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRFLFILETIIVIV